Open AccessA third case of vancomycin-resistant MRSA in the United States
Author(s) -
A.P. Johnson
Publication year - 2004
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.08.18.02455-en
Subject(s) - vancomycin , glycopeptide , staphylococcus aureus , methicillin resistant staphylococcus aureus , microbiology and biotechnology , medicine , antibiotics , biology , bacteria , genetics
The glycopeptide vancomycin is, for many, currently the drug of choice for treating infections due to methicillin-resistant Staphylococcus aureus (MRSA)